Claudia Bellofiore

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian Centers.

Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian Centers.

Journal: Diseases (Basel, Switzerland)

Published: December 17, 2025

Eligibility criteria for clinical trials in AL amyloidosis result in exclusion of nearly half of real-world patients.

Eligibility criteria for clinical trials in AL amyloidosis result in exclusion of nearly half of real-world patients.

Journal: HemaSphere

Published: October 13, 2025

Predictors of Early Death in Patients With Wild-Type Transthyretin Cardiac Amyloidosis.

Predictors of Early Death in Patients With Wild-Type Transthyretin Cardiac Amyloidosis.

Journal: Journal of the American Heart Association

Published: December 24, 2024

Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis.

Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis.

Journal: JACC. CardioOncology

Published: December 17, 2024

Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study.

Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study.

Journal: Blood advances

Published: December 13, 2024

Daratumumab-based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case-control study.

Daratumumab-based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case-control study.

Journal: HemaSphere

Published: November 17, 2024

Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis.

Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: July 11, 2024

Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab.

Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab.

Journal: Current oncology reports

Published: May 23, 2024

A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.

A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.

Journal: Hematological oncology

Published: March 11, 2024

Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study.

Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study.

Journal: Cancers

Published: June 05, 2023

Development and Validation of Staging Systems for AA Amyloidosis.

Development and Validation of Staging Systems for AA Amyloidosis.

Journal: Journal of the American Society of Nephrology : JASN

Published: March 28, 2023

Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival.

Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival.

Journal: Blood

Published: March 17, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026